These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Evolving concepts in the treatment of venous thromboembolism: the role of factor Xa inhibitors. Nutescu EA; Helgason CM Pharmacotherapy; 2004 Jul; 24(7 Pt 2):82S-87S. PubMed ID: 15317403 [TBL] [Abstract][Full Text] [Related]
6. Assessing, preventing, and treating venous thromboembolism: evidence-based approaches. Nutescu EA Am J Health Syst Pharm; 2007 Jun; 64(11 Suppl 7):S5-13. PubMed ID: 17519445 [TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280 [TBL] [Abstract][Full Text] [Related]
8. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. Akl EA; Rohilla S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann HJ Cochrane Database Syst Rev; 2008 Jan; (1):CD006649. PubMed ID: 18254108 [TBL] [Abstract][Full Text] [Related]
9. The role of ximelagatran in the treatment of venous thromboembolism. Schulman S Pathophysiol Haemost Thromb; 2005; 34 Suppl 1():18-24. PubMed ID: 15812200 [TBL] [Abstract][Full Text] [Related]
10. Low molecular weight heparins in the long-term treatment of venous thromboembolism. Liapis CD; Daskalopoulos ME; Daskalopoulou SE J Cardiovasc Surg (Torino); 2002 Aug; 43(4):495-500. PubMed ID: 12124561 [TBL] [Abstract][Full Text] [Related]
11. Management of venous thromboembolism in the elderly. Spyropoulos AC; Merli G Drugs Aging; 2006; 23(8):651-71. PubMed ID: 16964988 [TBL] [Abstract][Full Text] [Related]
12. Emerging options in the treatment of venous thromboembolism. Nutescu EA Am J Health Syst Pharm; 2004 Dec; 61(23 Suppl 7):S12-7. PubMed ID: 15597574 [TBL] [Abstract][Full Text] [Related]
13. Emerging anticoagulants for the treatment of venous thromboembolism. Weitz JI Thromb Haemost; 2006 Sep; 96(3):274-84. PubMed ID: 16953267 [TBL] [Abstract][Full Text] [Related]
14. Fondaparinux sodium: a review of its use in the treatment of acute venous thromboembolism. Robinson DM; Wellington K Am J Cardiovasc Drugs; 2005; 5(5):335-46. PubMed ID: 16156690 [TBL] [Abstract][Full Text] [Related]
15. Selecting an anticoagulant for recurrent venous thromboembolism in cancer. Goodin S Am J Health Syst Pharm; 2005 Nov; 62(22 Suppl 5):S10-3. PubMed ID: 16286363 [TBL] [Abstract][Full Text] [Related]
16. Long-term treatment of venous thromboembolism with low-molecular-weight heparin. Monreal M Curr Opin Pulm Med; 2000 Jul; 6(4):326-9. PubMed ID: 10912641 [TBL] [Abstract][Full Text] [Related]
17. Management of thromboembolism in patients with cancer. Viale PH Oncol Nurs Forum; 1999; 26(10):1625-32; quiz 1633-4. PubMed ID: 10573679 [TBL] [Abstract][Full Text] [Related]
18. Emerging anticoagulants: mechanism of action and future potential. Klement P; Rak J Vnitr Lek; 2006 Mar; 52 Suppl 1():119-22. PubMed ID: 16637459 [TBL] [Abstract][Full Text] [Related]
19. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants. Hillis C; Crowther MA Thromb Haemost; 2015 Jun; 113(6):1193-202. PubMed ID: 25948149 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of venous thrombosis in cancer patients: practical aspects]. Laza-Achille M; Desruennes E; Di Palma M Bull Cancer; 2006 Mar; 93(3):271-81. PubMed ID: 16567314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]